tiprankstipranks
Advertisement
Advertisement

INMB Stock Latest News

INmune Bio Earnings Call Highlights De-Risking, Cash Risks
Company AnnouncementsINmune Bio Earnings Call Highlights De-Risking, Cash Risks
2d ago
INMB
Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
PremiumRatings
Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
11d ago
INMB
INmune Bio Strengthens Cash Runway With R&D Rebates
PremiumCompany Announcements
INmune Bio Strengthens Cash Runway With R&D Rebates
24d ago
8K
INMB
INmune Bio receives $4.6M in rebates from Australia, UK
PremiumThe Fly
INmune Bio receives $4.6M in rebates from Australia, UK
25d ago
INMB
INmune Bio processes first umbilical cord tissue at CGT Catapult
PremiumThe Fly
INmune Bio processes first umbilical cord tissue at CGT Catapult
1M ago
INMB
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
PremiumRatingsStrengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
2M ago
INMB
INmune Bio Executes Warrant Inducement and Extension Agreement
Premium
Company Announcements
INmune Bio Executes Warrant Inducement and Extension Agreement
2M ago
8K
INMB
INmune Bio advances CORDStrom platform patent application in the U.S.
Premium
The Fly
INmune Bio advances CORDStrom platform patent application in the U.S.
2M ago
INMB
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan
PremiumThe Fly
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan
2M ago
INMB
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
PremiumCompany Announcements
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
2M ago
8K
INMB
INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
PremiumThe Fly
INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
2M ago
INMB
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
PremiumCompany Announcements
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
2M ago
8K
INMB
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
PremiumRatingsMaintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
3M ago
INMB
INmune Bio reports positive Phase 2 MRI results
Premium
Company Announcements
INmune Bio reports positive Phase 2 MRI results
3M ago
8K
INMB
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
Premium
The Fly
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
3M ago
INMB
Inmune Bio Charts Regulatory Path Amid Cash Constraints
PremiumCompany Announcements
Inmune Bio Charts Regulatory Path Amid Cash Constraints
3M ago
INMB
INmune Bio publishes MINDFuL trial results in NPJ Dementia
PremiumThe Fly
INmune Bio publishes MINDFuL trial results in NPJ Dementia
3M ago
INMB
INmune Bio Receives FDA Fast Track for XPro
PremiumCompany Announcements
INmune Bio Receives FDA Fast Track for XPro
3M ago
8K
INMB
INmune Bio receives fast track designation from FDA for XPro
PremiumThe Fly
INmune Bio receives fast track designation from FDA for XPro
3M ago
INMB
Inmune Bio Advances CORDStrom Amid Funding Pressures
PremiumCompany AnnouncementsInmune Bio Advances CORDStrom Amid Funding Pressures
4M ago
INMB
INmune Bio Expands Cord Tissue License for CORDStrom Platform
Premium
Company Announcements
INmune Bio Expands Cord Tissue License for CORDStrom Platform
4M ago
8K
INMB
INmune Bio announces new preclinical data for INB03
Premium
The Fly
INmune Bio announces new preclinical data for INB03
4M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >